Clinical trials: Gender Dysphoria
Gender Dysphoria
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria.
- Trial name
- NCT05903911
- Testing
- Trans Care Web App
- Where
- United States
- Volunteers
- 312 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Gender Dysphoria
Gender Dysphoria in Children and Adolescents : Parents' Perspectives
Gender dysphoria is defined as a persistent incongruence between an experienced gender and the assigned sex at birth Transgender and gender nonconforming persons desire to modify their appearance to be consistent with their…
- Trial name
- GeDyPar (NCT04160364)
- Testing
- qualitative study
- Where
- France
- Volunteers
- 20 people
- Sponsor
- Central Hospital, Nancy, France
Gender Identity, Gender Dysphoria
Pubertal Blockade and Hormone Therapy in Transgender Youth
This study will enroll female-to-male transgender youth who are and are not on a puberty blocker (gonadotropin-releasing hormone analogue) at baseline and 1 and 12 months after starting testosterone.
- Conditions
- Gender Identity, Gender Dysphoria, Gender Identity Disorder in Adolescence and Adulthood
- Trial name
- PUBErTY (NCT03557268)
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- University of Colorado, Denver
Gender Dysphoria, Gender Identity Disorder
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
i2TransHealth is a randomized controlled trial that investigates the outcomes of an internet-based health care approach for transgender and gender diverse (TGD) people.
- Conditions
- Gender Dysphoria, Gender Identity Disorder, Transsexualism, Gender Identity
- Trial name
- NCT04290286
- Testing
- i2TransHealth
- Where
- Germany
- Volunteers
- 186 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Gender Dysphoria
Effects of Gender-affirming Hormone Therapy on Transgender People
This prospective cohort study aims to assess the impact of gender-affirming hormone therapy (GAHT) on transgender individuals' physical, psychological, social, and quality of life aspects.
- Trial name
- NCT06022562
- Where
- Taiwan
- Volunteers
- 227 people, healthy volunteers welcome
- Sponsor
- National Taiwan University
Gender Dysphoria, Adolescent
Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone
Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth.
- Trial name
- NCT05726903
- Testing
- Depo-subQ Provera Injectable Product
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Gender Incongruence, Transgenderism
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.
- Trial name
- NCT04551144
- Testing
- testosterone cypionate, Estradiol Valerate
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- St. Louis University
Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
A European Network for the Investigation of Gender Incongruence
The physical and psychological effects of the hormonal treatment of transsexual persons are not sufficiently described. 'Transparency' wants to answer this question in a prospective manner, in a multicenter study to describe…
- Trial name
- ENIGI (NCT01072825)
- Testing
- questionnaires, blood sampling, clinical evaluation
- Where
- 4 sites in Belgium, Italy and 2 more
- Volunteers
- 125 people
- Sponsor
- University Hospital, Ghent
Transgender, Gender Incongruence
China Gender-affirming Hormone Therapy Study
Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hormonal treatment in Chinese…
- Trial name
- CGAHT (NCT05318755)
- Testing
- GAHT for transgender men, GAHT for transgender women
- Where
- China
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Peking University Third Hospital
Transsexualism
GEnder Dysphoria Treatment in Sweden
Gender dysphoria (DSM-5) or transsexualism (ICD10) is a condition in which a person's feeling of gender identity is not congruent with the physical body.
- Trial name
- GETS (NCT02518009)
- Testing
- Genetic men treated with estrogen, Genetic women treated with androgen
- Where
- Sweden
- Volunteers
- 40 people
- Sponsor
- Karolinska Institutet
Gender Dysphoria, Mastectomy
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
The goal of this randomized, prospective, interventional clinical trial is to evaluate the use of Brijjit® in reducing the incidence of hypertrophic scarring in individuals undergoing gender-affirming bilateral double incision…
- Conditions
- Gender Dysphoria, Mastectomy, Hypertrophic Scar
- Trial name
- FMTB Brij (NCT07147166)
- Testing
- Brijjit® BP100-6 and BP-75, Control: Standard of care and normal wound dressing
- Where
- United States
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco